Therapeutic methods using prostaglandin EP4 agonist components
    44.
    发明授权
    Therapeutic methods using prostaglandin EP4 agonist components 有权
    使用前列腺素EP4激动剂组分的治疗方法

    公开(公告)号:US07893107B2

    公开(公告)日:2011-02-22

    申请号:US11291694

    申请日:2005-11-30

    IPC分类号: A61K31/19

    摘要: Methods are provided directed to administering a therapeutically effective amount of a prostaglandin EP4 agonist component to a mammal afflicted with or prone to afflicted with a disease or condition selected from an esophageal ulcer, alcohol gastropathy, a duodenal ulcer, non-steroidal anti-inflammatory drug-induced gastropathy, non-steroidal anti-inflammatory drug-induced enteropathy and intestinal ischemia. Such administration results in treating the disease or condition.

    摘要翻译: 提供的方法涉及将治疗有效量的前列腺素EP4激动剂组分施用于患有或易于患有选自食管溃疡,酒精胃食管炎,十二指肠溃疡,非甾体抗炎药物的疾病或病症的哺乳动物 诱发的胃病,非甾体抗炎药物引起的肠病和肠缺血。 这种给药导致治疗疾病或病症。

    Therapeutic methods using prostaglandin EP4 agonist components
    45.
    发明申请
    Therapeutic methods using prostaglandin EP4 agonist components 有权
    使用前列腺素EP4激动剂组分的治疗方法

    公开(公告)号:US20070123568A1

    公开(公告)日:2007-05-31

    申请号:US11291694

    申请日:2005-11-30

    IPC分类号: A61K31/558 A61K31/557

    摘要: Methods are provides directed to administering a therapeutically effective amount of a prostaglandin EP4 agonist component to a mammal afflicted with or prone to affliction with a disease or condition selected from an esophageal ulcer, alcohol gastropathy, a duodenal ulcer, non-steroidal anti-inflammatory drug-induced gastroentroeropathy and intestinal ischemia. Such administration results in treating or preventing the disease or condition.

    摘要翻译: 提供的方法涉及将治疗有效量的前列腺素EP 4激动剂组分施用于患有或易于患有选自食管溃疡,酒精性胃病,十二指肠溃疡的疾病或病症的哺乳动物 ,非甾体抗炎药物诱导的胃肠病和肠缺血。 这种给药导致治疗或预防疾病或病症。